CTKB EBITDA Margin
Cytek Biosciences Inc · EBITDA Margin
CTKB EBITDA Margin
Latest reported-17.40%period ending
CTKB Quarterly EBITDA Margin (-3.09% → -17.40%)
Quarterly ebitda margin
High-resolution chart · PNG
CTKB ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -17.4013% | |
| -32.3961% | |
| -0.4232% | |
| -8.0604% | |
| -7.3966% | |
| -19.5166% | |
| -4.2679% | |
| 5.9903% | |
| -9.8076% | |
| -13.58% | |
| 11.9005% | |
| -2.1479% | |
| -7.5282% | |
| -17.7038% | |
| 13.7889% | |
| 8.0787% | |
| 0.2789% | |
| -3.5449% | |
| 4.1677% | |
| 7.8689% | |
| 12.8289% | |
| 2.8593% | |
| 27.7279% | |
| 28.2037% | |
| 1.8499% | |
| -3.0909% |